Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Interest Coverage Ratio (2016 - 2019)

Vistagen Therapeutics' Interest Coverage Ratio history spans 8 years, with the latest figure at 3975.33 for Q4 2019.

  • For Q4 2019, Interest Coverage Ratio rose 199.49% year-over-year to 3975.33; the TTM value through Sep 2020 reached 10427.87, up 291.05%, while the annual FY2018 figure was 1595.46, 28.39% up from the prior year.
  • Interest Coverage Ratio for Q4 2019 was 3975.33 at Vistagen Therapeutics, up from 3995.72 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3975.33 in Q4 2019 and bottomed at 8501.0 in Q1 2016.
  • The 5-year median for Interest Coverage Ratio is 1664.67 (2017), against an average of 1927.87.
  • The largest annual shift saw Interest Coverage Ratio tumbled 40614.44% in 2016 before it soared 199.49% in 2019.
  • A 5-year view of Interest Coverage Ratio shows it stood at 714.0 in 2015, then crashed by 269.33% to 2637.0 in 2016, then skyrocketed by 45.62% to 1434.0 in 2017, then plummeted by 178.64% to 3995.72 in 2018, then soared by 199.49% to 3975.33 in 2019.
  • Per Business Quant, the three most recent readings for VTGN's Interest Coverage Ratio are 3975.33 (Q4 2019), 3995.72 (Q4 2018), and 2477.33 (Q3 2018).